Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and lipid peroxyl radicals are highly reactive chemical entities that play a critical role in cellular redox homeostasis and signaling. When produced in excess, these species target the polyunsaturated fatty acids within biological membranes, initiating a destructive chain reaction known as lipid peroxidation [1]. This process leads to the formation of toxic lipid hydroperoxides and reactive aldehydes, such as malondialdehyde, which can damage proteins and DNA [2]. The accumulation of lipid peroxyl radicals is a defining feature of ferroptosis, a non-apoptotic form of cell death linked to various pathological states including neurodegeneration and organ injury [3]. Consequently, these radicals are significant therapeutic targets in diseases characterized by oxidative stress, such as Amyotrophic Lateral Sclerosis (ALS) and ischemia-reperfusion injury [4]. Pharmacological strategies involve the use of radical-trapping antioxidants (RTAs) and scavengers, such as edaravone and alpha-tocopherol, which neutralize these species to prevent membrane degradation [5][6]. Effective targeting requires molecules with sufficient lipophilicity to access the hydrophobic core of the lipid bilayer where these radicals reside [1]. [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920909/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617710/ [3] https://www.nature.com/articles/s41419-020-03007-3 [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350122/ [5] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209175s000lbl.pdf [6] https://pubmed.ncbi.nlm.nih.gov/21248165/
Radical scavenging and termination of lipid peroxidation chain reactions by donating hydrogen atoms or electrons to neutralize reactive species.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and lipid peroxyl radicals (ROS/LOO•).